CVRX
CVRxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CVRX Profile
Cvrx, Inc.
A commercial-stage medical device company focused on innovative neuromodulation solutions for cardiovascular diseases
Healthcare Equipment and Supplies
--
06/30/2021
NASDAQ Stock Exchange
206
12-31
Common stock
9201 West Broadway Avenue, Suite 650, Minneapolis, MN 55445
--
CVRx, Inc., was incorporated in Delaware in August 2000. CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Their proprietary platform technology, Barostim, is the first medical technology approved by the US Food and Drug Administration to use neuromodulation to improve symptoms in patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the walls of the carotid artery. Barostim provides Baroreflex activation therapy, which in turn triggers an autonomic nervous response to the heart. The therapy aims to restore the balance of the autonomic nervous system, thereby reducing the symptoms of arrhythmia.
